Research indicates that the loss of miR-26b-5p can lead to enhanced inflammation-related GC progression, primarily through the activation of a feedback loop involving PDE4B, CDK8, and STAT3 signaling pathways [117]. This evidence concerns the gene PDE4B and gastric cancer.